Published on

Ophthalmology – Foveal Hypoplasia

Basics

Description

Foveal hypoplasia is a congenital developmental abnormality in which the fovea fails to develop normally. Because the fovea is responsible for high-resolution central vision, incomplete foveal specialization can result in reduced visual acuity and nystagmus.

Funduscopic examination typically demonstrates an absent or poorly developed foveal pit and foveal light reflex. The normal foveal avascular zone may be absent, allowing retinal vessels to pass unusually close to or directly across the expected center of the fovea.

The remainder of the retina and the optic nerves may appear normal, particularly in isolated foveal hypoplasia.

Visual acuity is variable and depends on the severity of the developmental abnormality and associated ocular conditions. Historically, acuities around 20/100 to 20/200 have been described in more significant cases, although milder forms can have substantially better vision.

Epidemiology

The true incidence and prevalence of foveal hypoplasia are unknown. The condition is uncommon and may occur either as an isolated ocular abnormality or as part of a genetic or developmental syndrome.

Risk Factors

Foveal hypoplasia is strongly associated with albinism and aniridia. A positive family history of foveal hypoplasia or an associated inherited disorder increases the likelihood of the diagnosis.

Genetics

The genetic basis depends on whether foveal hypoplasia occurs in isolation or as part of another disorder.

When associated with aniridia or albinism, the inheritance pattern generally follows that of the underlying condition.

Mutations involving PAX6, located on chromosome 11p13, can cause aniridia-associated foveal hypoplasia and some forms of isolated foveal hypoplasia.

Autosomal recessive forms have also been described, including foveal hypoplasia associated with anterior segment dysgenesis.

Foveal hypoplasia has additionally been reported in association with Axenfeld–Rieger spectrum disorders and other genetic conditions.

Prevention

Because foveal hypoplasia results from abnormal development of the fovea, there is no method for preventing the ocular abnormality after development has occurred.

When a causative mutation or inherited syndrome is identified, genetic counseling can help affected individuals and families understand inheritance patterns and recurrence risks. Prenatal or other genetic testing may be available for selected known mutations.

Pathophysiology

Foveal hypoplasia results from incomplete differentiation and specialization of the central retina during development.

Normal foveal development involves displacement of the inner retinal layers away from the center of the macula, formation of the foveal pit, specialization and elongation of the photoreceptors, and development of a foveal avascular zone.

In foveal hypoplasia, these developmental events are incomplete. Consequently, the inner retinal layers may persist across the foveal center, the foveal pit may be shallow or absent, and retinal vessels may cross the area where the normal foveal avascular zone should be located.

In albinism, deficient melanin within the retinal pigment epithelium is associated with abnormal foveal development.

In PAX6-related disorders, including aniridia, disruption of developmental gene regulation interferes with normal macular differentiation.

Etiology

The condition is believed to result from incomplete embryologic and postnatal development of the fovea.

Normal foveal maturation progresses from an initially indistinct central retinal area toward formation of the annular reflex, development of the foveal pit, and finally appearance of the mature foveal reflex.

Interruption or failure of these developmental processes produces varying degrees of foveal hypoplasia.

Associated Conditions

Important associated disorders include albinism, aniridia, achromatopsia, and congenital nystagmus.

Less commonly, foveal hypoplasia may occur with Axenfeld–Rieger spectrum abnormalities and other developmental or genetic ocular disorders.

Reduced visual acuity is common. Strabismus and amblyopia may develop, particularly when visual function is asymmetric between the two eyes.

Diagnosis

History

Patients usually present with reduced vision beginning in infancy or childhood. Parents may first notice abnormal visual behavior or involuntary eye movements.

Infantile nystagmus is a frequent presenting feature.

Some patients are diagnosed during evaluation for an associated disorder such as albinism or aniridia. Mild isolated foveal hypoplasia may remain undetected until later childhood or adulthood.

A family history of poor vision, nystagmus, albinism, aniridia, or similar ocular abnormalities should be obtained.

Physical Examination

A complete ophthalmologic examination should be performed, with particular attention to the macula.

Funduscopic examination may reveal absence or reduction of the normal foveal light reflex and foveal pit.

The normal foveal avascular zone may be poorly developed or absent. Retinal vessels may extend unusually close to or directly across the presumed foveal center.

The examiner should assess visual acuity, fixation behavior, refractive error, ocular alignment, and nystagmus.

The iris, anterior segment, optic nerves, and peripheral retina should also be examined carefully for evidence of an associated condition such as aniridia or albinism.

Diagnostic Testing

Optical Coherence Tomography

Optical coherence tomography (OCT) is the most useful imaging technique for confirming and grading foveal hypoplasia.

OCT can demonstrate characteristic persistence of the inner retinal layers through the foveal center and absence or reduction of the normal foveal depression.

Other findings can include abnormal retinal thickness, reduced or absent widening of the outer nuclear layer, and incomplete specialization or elongation of the photoreceptor outer segments.

Modern OCT-based grading systems can classify the severity of foveal hypoplasia according to the degree of structural development. In general, more severe structural abnormalities are associated with poorer visual acuity.

Laboratory and Genetic Evaluation

Routine laboratory investigations are generally not required for isolated foveal hypoplasia.

Molecular genetic testing should be considered when there is suspicion of an inherited disorder, particularly in patients with aniridia, albinism, anterior segment dysgenesis, achromatopsia, a positive family history, or apparently isolated congenital foveal hypoplasia.

Referral to ocular genetics may help determine the most appropriate testing strategy.

Additional Testing

Visual-field testing may occasionally be useful in cooperative patients, particularly when another optic nerve or retinal disorder is being considered.

Additional electrophysiologic or retinal testing may be appropriate when a retinal or cone dystrophy is part of the differential diagnosis.

Pathological and Structural Findings

The principal structural abnormality is failure of normal foveal differentiation.

The ganglion cell and other inner retinal layers may continue across the macular center rather than being displaced centrifugally as they are in a normally developed fovea.

The normal foveal avascular zone may be absent.

Developmental abnormalities of the visual system beyond the retina have also been reported, including changes involving the optic pathways and visual cortex, particularly in syndromic conditions.

Differential Diagnosis

Foveal hypoplasia should be differentiated from other disorders that alter the appearance or position of the macula.

Important considerations include epiretinal membrane, macular dragging from retinopathy of prematurity or familial exudative vitreoretinopathy, high myopia, retinal vascular anomalies, and retinal or macular dystrophies.

A lightly pigmented or blonde fundus can make identification of the fovea difficult but does not necessarily indicate foveal hypoplasia.

Optic nerve hypoplasia and optic atrophy can also produce reduced vision and nystagmus but have different structural findings.

OCT is particularly valuable in distinguishing true developmental foveal hypoplasia from these conditions.

Treatment

There is no medical or surgical treatment capable of creating a normally developed fovea once foveal development is complete.

Management therefore focuses on maximizing the patient’s existing visual potential and treating associated ocular abnormalities.

Optical Correction

Refractive errors should be corrected accurately with spectacles or contact lenses.

Even when central vision is limited by foveal hypoplasia, correction of refractive error can produce meaningful functional improvement.

Amblyopia Treatment

If visual acuity is asymmetric and amblyopia is suspected, appropriate amblyopia therapy should be instituted during the period of visual development.

Early treatment is important because amblyopia represents an additional potentially preventable source of visual loss.

Photophobia

Patients with albinism, aniridia, or other conditions associated with significant photophobia may benefit from tinted or light-filtering lenses.

Low-Vision Rehabilitation

Patients with significant permanent reduction in central vision should be referred for low-vision evaluation and rehabilitation.

Depending on age and functional requirements, magnification devices, electronic aids, educational accommodations, and other assistive technologies can improve reading and daily functioning.

Surgical Treatment

There is no surgical procedure for foveal hypoplasia itself.

Associated strabismus may be treated surgically when appropriate.

Selected patients with significant nystagmus and an abnormal head posture may undergo nystagmus-related surgery. Such procedures may improve head position or certain functional aspects of vision, but they generally do not restore normal foveal visual acuity.

Follow-Up

Follow-up depends on the patient’s age, visual function, and associated disorders.

Children require monitoring of visual development, refractive error, amblyopia, strabismus, and nystagmus.

Patients with associated aniridia or albinism require continued surveillance for complications related to those underlying disorders.

Low-vision needs should be reassessed as educational, occupational, and daily visual demands change.

Patient Monitoring

Particular attention should be given to asymmetric visual acuity because amblyopia can coexist with structural foveal abnormalities and should not automatically be attributed to the foveal hypoplasia.

Ocular alignment and refractive error should also be monitored throughout childhood.

Prognosis

Visual prognosis depends primarily on the degree of foveal development and the presence of associated ocular or systemic abnormalities.

Mild foveal hypoplasia may permit relatively good functional vision, whereas severe developmental abnormalities can produce substantial lifelong reduction in central visual acuity.

Extensive abnormal macular vascularization, including vessels extending close to or across the presumed foveal center, has historically been associated with more severe hypoplasia and poorer visual function.

Because the structural abnormality is congenital, vision lost directly from severe foveal hypoplasia generally cannot be restored. However, maximizing refractive correction and treating amblyopia and strabismus can substantially improve the patient’s usable visual potential.

Complications

The major consequences are low vision and nystagmus.

Patients may also develop amblyopia and strabismus, particularly when the two eyes are affected unequally.

Associated disorders such as albinism and aniridia may produce additional ocular complications that require separate long-term surveillance and treatment.


Image description
Published on

Ophthalmology – Intraorbital Foreign Body

Basics

Description

An intraorbital foreign body (IOFB) is an object that penetrates and becomes retained within the orbit. It most commonly results from a high-velocity penetrating injury or direct impalement by a sharp object.

Foreign bodies may enter through the eyelid or conjunctiva and can damage the globe, extraocular muscles, optic nerve, orbital vessels, orbital walls, or even extend intracranially. The severity depends greatly on the composition, size, velocity, and location of the object and the associated injuries produced at the time of penetration.

Epidemiology

Most patients with intraorbital foreign bodies are young males, commonly younger than 30 years of age. This pattern reflects greater exposure to occupational, recreational, projectile, and traumatic injuries.

Prevention

The most important preventive measures are education and appropriate protective eyewear during high-risk occupational and recreational activities.

Eye protection is particularly important when working with machinery, metal, wood, construction materials, firearms, or other sources of high-velocity projectiles.

Pathophysiology

An IOFB develops when an object penetrates the periocular tissues and enters the orbit through the eyelid, conjunctiva, or adjacent structures.

The foreign body can cause immediate mechanical damage to orbital structures. Subsequent complications depend heavily on the material retained.

Organic materials, particularly wood and plant matter, provoke substantial inflammation and can introduce microorganisms into the orbit. They therefore carry a high risk of infection, abscess formation, and chronic granulomatous inflammation.

Many inert inorganic materials, such as certain metals, glass, or plastic, may remain relatively well tolerated when deeply located and not causing functional problems.

Etiology

Projectile injuries are an important cause. Metallic foreign bodies may result from BB or pellet injuries, firearms, industrial accidents, or fragments produced during metalworking.

Nonmetallic objects may also penetrate the orbit. These can be organic, such as tree branches or wooden fragments, or inorganic, such as glass, plastic, and stone.

The nature of the material is clinically important because organic material generally produces a much greater inflammatory and infectious response than inert inorganic material.

Diagnosis

History

A history of periocular or orbital trauma is usually present, but the original injury may appear deceptively minor.

Delayed presentation is not uncommon. This is particularly important in children or in patients who were intoxicated or otherwise unable to provide an accurate history at the time of injury.

A retained foreign body should therefore be considered in a patient with otherwise unexplained recurrent orbital inflammation, orbital cellulitis, draining sinus, abscess, proptosis, or ocular motility disturbance, particularly when there is a remote history of trauma.

The mechanism of injury should be established whenever possible because it provides information about the likely material, trajectory, velocity, and risk of intracranial penetration.

Physical Examination

Visual acuity should be assessed as soon as safely possible. Vision may range from completely normal to profound or complete visual loss depending on associated globe, optic nerve, or orbital injury.

An afferent pupillary defect may indicate significant optic nerve or retinal involvement.

Extraocular movements should be assessed carefully. Limitation of movement may result from direct extraocular muscle injury, mechanical restriction, inflammation, or nerve injury.

Other possible findings include blepharoptosis, proptosis, orbital swelling, and inflammation.

A foreign body located near the orbital apex may occasionally produce gaze-evoked visual loss, suggesting compression or compromise of the optic nerve or its blood supply with certain eye positions.

The periocular skin and conjunctiva should be examined carefully for an entry wound. The conjunctival fornices deserve particular attention because a small penetration site may easily be overlooked.

The examination must also determine whether there is an associated open-globe injury, which substantially changes subsequent management.

Laboratory Investigation

If infection is suspected, material from the wound or foreign body should be submitted for appropriate aerobic, anaerobic, and fungal cultures.

A complete blood count may demonstrate leukocytosis in patients with significant acute or chronic orbital infection or inflammation, although normal laboratory findings do not exclude a retained foreign body.

Imaging

CT Scan

Orbital CT is generally the key initial imaging study in penetrating orbital trauma. It is particularly effective at identifying and localizing metallic and glass foreign bodies and evaluating associated orbital fractures.

Thin-section images in appropriate planes help determine the foreign body’s location and relationship to the globe, optic nerve, extraocular muscles, and orbital walls.

Wooden foreign bodies can be challenging because their CT appearance changes depending on their water content and duration within the orbit. Dry wood may have very low attenuation and can resemble air, while retained wood may later become more conspicuous as it absorbs fluid and induces inflammation.

MRI

MRI can be useful when CT is unrevealing but there remains strong clinical suspicion for an organic or other radiolucent nonmetallic foreign body.

However, MRI should not be performed until a ferromagnetic metallic foreign body has been reliably excluded, because movement of ferromagnetic material within the magnetic field can cause additional tissue injury.

Ultrasonography

Ultrasound can occasionally assist in localization, particularly for more anterior lesions, but it is less reliable for evaluating the orbital apex.

Ultrasonography also requires particular caution when an open-globe injury is suspected, because pressure on a potentially ruptured globe should be avoided.

Intracranial Extension

Any penetrating injury with a trajectory toward the orbital roof, superior orbital fissure, or orbital apex should raise concern for orbitocranial penetration.

This is especially important in children because their orbital bones are relatively thin. Appropriate CT imaging should evaluate the orbit, brain, and suspected trajectory of the penetrating object.

Additional Diagnostic Testing

When an iron- or copper-containing foreign body lies close to the sclera or globe, electroretinography (ERG) may occasionally be useful to evaluate retinal toxicity.

The need for additional testing depends on the composition and location of the foreign body and associated ocular injury.

Pathological Findings

Retained organic foreign bodies commonly produce chronic inflammation. Histopathology may demonstrate a foreign-body granulomatous reaction, fibrosis, inflammatory cellular infiltration, and occasionally abscess formation.

This strong inflammatory response explains why retained wood and other organic materials generally require removal.

Differential Diagnosis

A retained IOFB should be distinguished from conditions producing similar orbital inflammation or mass effect, particularly orbital cellulitis, idiopathic orbital inflammation, and orbital neoplasms.

In a child with unexplained orbital inflammation or an apparent orbital mass, an occult penetrating injury and retained foreign body should remain in the differential diagnosis.

Treatment

Management depends on the material, location, accessibility, associated injuries, infection, ocular motility, neurologic status, and visual function.

The presence of a foreign body does not automatically mean that every object should be surgically removed. Attempted removal of a deeply located inert object can sometimes cause more damage than leaving it undisturbed.

Medical Treatment

Patients with contaminated penetrating injuries require appropriate tetanus prophylaxis according to their immunization status and wound characteristics.

When orbital cellulitis or another infection is present, broad-spectrum antimicrobial treatment is required. Coverage should reflect the mechanism of injury and suspected organisms, with appropriate anaerobic coverage for contaminated wounds.

Organic foreign bodies have a particularly high risk of polymicrobial and fungal infection and require aggressive evaluation and management.

Surgical Treatment

Surgical removal is generally indicated when the foreign body causes neurologic compromise, significant ocular motility restriction, infection, abscess formation, optic nerve compromise, or other orbital complications.

Organic foreign bodies should generally be removed because of their high risk of infection and chronic inflammatory reactions.

Accessible foreign bodies in the anterior orbit are also more likely to be removed because surgery can often be performed with relatively limited risk.

In contrast, a deeply located inert inorganic foreign body in the posterior orbit may sometimes be observed when it is not causing infection, visual dysfunction, motility disturbance, or other complications. Attempting to retrieve an object adjacent to the orbital apex or optic nerve may itself threaten vision.

Intraoperative imaging or localization techniques, including ultrasound or fluoroscopy, may occasionally assist in identifying difficult-to-localize foreign bodies.

Associated globe injuries should be addressed appropriately as part of the overall surgical plan.

Referral and Multidisciplinary Management

Patients require urgent ophthalmologic assessment, particularly when there is decreased vision, suspected open-globe injury, optic neuropathy, significant motility disturbance, or orbital infection.

An oculoplastic or orbital surgeon may be required for removal of complex foreign bodies.

If imaging demonstrates or strongly suggests intracranial penetration, neurosurgical involvement is essential.

Follow-Up

Follow-up should assess visual acuity, pupillary responses, ocular motility, globe integrity, optic nerve function, orbital inflammation, and signs of infection.

Patients in whom an inorganic foreign body is intentionally retained require ongoing observation for delayed complications.

Organic foreign bodies require particularly careful follow-up because infection or inflammatory complications may develop even after an initially quiet period.

Prognosis

Visual prognosis depends primarily on the severity of the initial injury, particularly damage to the globe, retina, optic nerve, or orbital apex.

Many retained inert metallic foreign bodies are well tolerated and may have a good prognosis when they do not directly damage important orbital structures.

The composition of the metal matters. Copper-containing foreign bodies can provoke severe chronic inflammatory or suppurative reactions.

Organic materials have a less favorable prognosis because they carry a substantially greater risk of orbital infection, abscess formation, chronic inflammation, and intracranial infection.

Complications

Potential complications include orbital cellulitis, orbital abscess, chronic suppurative inflammation, sterile abscess formation, orbitocutaneous fistula, orbital wall osteomyelitis, ocular motility abnormalities, optic nerve injury, and permanent visual loss.

Penetrating injuries extending beyond the orbit may produce intracranial infection, cerebral injury, meningitis, or brain abscess, making recognition of orbitocranial extension particularly important.


Image description
Published on


Pharmacology - Writing a Prescription

Q1. What should be done before writing a prescription?

A: Before prescribing a medicine, review the patient’s current drug therapy carefully. This should also be done when rewriting an existing hospital drug chart.


Q2. What should you consider about the new medicine in relation to the patient’s existing treatment?

A: Ask how the new medicine will contribute to the current management of the disease. Consider whether it will:

  • Improve or relieve symptoms.
  • Modify the underlying pathophysiology of the disease.
  • Prevent the disease or slow its progression.


Q3. Why should other medical conditions be considered before prescribing?

A: A medicine prescribed for one condition may worsen another disease.

For example:

  • Diuretics used for heart failure may worsen gout.
  • Beta-blockers may trigger or worsen asthma.


Q4. Why is it important to check for drug interactions?

A: A newly prescribed medicine may interact with other medicines the patient is already taking, which can reduce effectiveness or increase adverse effects.


Q5. Which medicines should be considered when checking for interactions?

A: Consider all medicines the patient uses, including:

  • Medicines prescribed by other doctors, nurses, or pharmacists.
  • Over-the-counter medicines.
  • Herbal remedies.
  • Other non-prescribed medicines or substances.


Practical Prescription Writing

Q6. Which drug names should generally be used when writing prescriptions?

A: Prescribers are encouraged to use the recommended International Non-proprietary Name (rINN) rather than brand or proprietary names, because brand names may cause confusion.


Q7. Should abbreviations or acronyms be used for drug names?

A: No. Drug names should be written clearly and in full whenever possible.

For example, write glyceryl trinitrate instead of using the abbreviation GTN.


Q8. How should the dose of a medicine be written?

A: The dose should be stated clearly using appropriate units. Commonly accepted units include:

  • mg for milligrams.
  • mL for millilitres.


Q9. How should microgram doses be written?

A: The word “micrograms” should be written in full.

The symbol μg should be avoided because it may be misread as mg, potentially causing a serious dosing error.


Q10. How should drug doses expressed in units be written?

A: Write the word “units” in full.

Avoid abbreviations or symbols such as U, because they may be misread as a zero and result in an incorrect dose.


Q11. Why should decimal points be avoided when writing doses?

A: Decimal points may be overlooked or misread, which can lead to significant dosing errors.

For example, .5 mL could mistakenly be read as 5 mL.


Q12. How should a decimal dose be written when it is necessary?

A: Always place a zero before the decimal point.

For example:

  • Correct: 0.5 mL
  • Incorrect: .5 mL


Route of Administration

Q13. What routes of administration should be stated on a prescription?

A: The route by which the medicine should be administered must be clearly documented.

Commonly recognised abbreviations include:

  • po – by mouth.
  • im – intramuscularly.
  • iv – intravenously.
  • sc – subcutaneously.


Frequency of Administration

Q14. What does “od” mean on a prescription?

A: od means the medicine should be taken once daily.


Q15. What does “bd” mean?

A: bd means the medicine should be taken twice daily.


Q16. What does “tds” mean?

A: tds means the medicine should be taken three times daily.


Q17. What does “qds” mean?

A: qds means the medicine should be taken four times daily.


Q18. What does “prn” mean?

A: prn means the medicine should be given or taken when required.

When prescribing a medicine on a PRN basis, the maximum permitted daily dose should also be stated.


Q19. What does “stat” mean?

A: stat means the medicine should be administered immediately.


Special Instructions

Q20. What special instructions may need to be included on a prescription?

A: Additional instructions may be required to ensure that the medicine is taken correctly.

Examples include:

  • Dietary instructions, such as “take with food.”
  • Timing instructions, such as “take at night.”


Q21. Why are special instructions important?

A: They help ensure safe and effective medicine use and may improve absorption, reduce adverse effects, or ensure that the medicine is taken at the most appropriate time.


Completing the Prescription

Q22. What must be done after completing a prescription?

A: The prescription should be:

  • Signed by the prescriber.
  • Dated clearly.

This confirms who prescribed the medicine and when it was prescribed.


Q23. Are there additional requirements for controlled drugs?

A: Yes. Prescriptions for controlled drugs are subject to additional legal and documentation requirements, so the relevant prescribing regulations must be followed carefully.



Image description
Published on

Ophthalmology – Floppy Eyelid Syndrome

Basics

Description

Floppy eyelid syndrome (FES) is characterized by an abnormally loose, lax, and easily everted upper eyelid, typically associated with chronic papillary conjunctivitis. The upper eyelid may spontaneously evert during sleep, exposing the conjunctiva and ocular surface to repeated mechanical irritation.

The disorder may be unilateral or bilateral and has a particularly strong association with obstructive sleep apnea–hypopnea syndrome (OSAHS).

Epidemiology

Floppy eyelid syndrome occurs more commonly in males and is strongly associated with obesity and a high body mass index. Either one or both eyes may be affected.

The condition is particularly important because a large proportion of affected patients also have obstructive sleep apnea.

Risk Factors

The major risk factor is obstructive sleep apnea. Obesity and recurrent mechanical trauma to the eyelids, particularly from sleeping face-down or on one side and repeatedly rubbing the eyes, also contribute.

Patients often sleep preferentially on the side of the more severely affected eye.

Prevention

Recognition and treatment of associated obstructive sleep apnea are important. Treatment with continuous positive airway pressure (CPAP) may improve both the sleep apnea and manifestations of floppy eyelid syndrome.

Reducing chronic eye rubbing and mechanical trauma to the eyelids may also be beneficial.

Pathophysiology

The upper eyelid becomes abnormally lax because of structural abnormalities involving the tarsal plate and elastic tissue.

Repeated mechanical trauma during sleep and recurrent ischemia-reperfusion injury may increase the activity of matrix metalloproteinases, enzymes that degrade elastin. Progressive loss and alteration of elastic fibers weaken the eyelid and allow it to evert easily.

Once the eyelid begins everting during sleep, the exposed conjunctiva and cornea undergo repeated mechanical irritation, creating a cycle of inflammation, ocular surface exposure, and further eyelid damage.

Etiology

The precise cause is not completely understood. Important contributing mechanisms include elongation and weakening of the tarsal plate, chronic mechanical trauma, repeated eye rubbing, and abnormalities of elastic tissue.

Obstructive sleep apnea is strongly associated with the condition and may contribute through intermittent hypoxia and ischemia-reperfusion injury.

Associated Conditions

The most important association is obstructive sleep apnea–hypopnea syndrome, reported in a very high proportion of patients with classic floppy eyelid syndrome.

Other associations include obesity, keratoconus, chronic ocular surface disease, ptosis, and eyelid malposition.

Keratoconus may be particularly prominent on the side on which the patient habitually sleeps or rubs the eye.

OSA itself has important systemic associations, including cardiovascular disease, stroke, metabolic syndrome, cognitive and emotional disturbances, and excessive daytime sleepiness.

Diagnosis

History

Patients commonly report chronic ocular irritation, foreign-body sensation, redness, tearing, and mucous discharge. Symptoms are often particularly severe upon awakening in the morning.

Some patients are aware that their upper eyelid spontaneously turns outward while sleeping. They may report sleeping predominantly on the affected side of the face.

A history of loud snoring, witnessed apneic episodes, daytime somnolence, obesity, or previously diagnosed sleep apnea should be specifically sought.

Smoking and habitual eye rubbing should also be documented.

Physical Examination

The characteristic finding is an extremely lax upper eyelid that can be everted easily with minimal manipulation.

The upper tarsal plate often feels unusually soft and rubbery, and significant horizontal eyelid laxity may be present. The lower eyelid may also demonstrate increased laxity.

The eyelashes may point downward, producing lash ptosis.

Eversion of the upper eyelid commonly reveals chronic papillary conjunctivitis.

Other findings may include ptosis and lagophthalmos. Incomplete eyelid closure and nocturnal exposure may produce punctate epithelial keratitis, particularly when ocular surface disease is advanced.

Diagnostic Testing

Patients suspected of having associated obstructive sleep apnea should undergo appropriate evaluation, commonly including a sleep study or polysomnography.

This aspect of the evaluation is particularly important because untreated sleep apnea carries significant systemic morbidity.

The ophthalmic examination should carefully assess the cornea for punctate epithelial erosions, abrasions, ulceration, thinning, scarring, or other evidence of exposure-related disease.

Differential Diagnosis

Conditions that may resemble floppy eyelid syndrome include ptosis, chronic blepharoconjunctivitis, ectropion, vernal keratoconjunctivitis, giant papillary conjunctivitis, and superior limbic keratoconjunctivitis.

The combination of marked upper eyelid laxity, easy spontaneous eversion, chronic papillary conjunctivitis, and symptoms that are worse after sleep strongly favors floppy eyelid syndrome.

Treatment

First-Line Treatment

Initial treatment is directed toward protecting and lubricating the ocular surface.

Artificial tears may be used during the day, while more viscous gels or ophthalmic ointments provide longer-lasting protection and are particularly useful before sleep.

At night, the eyelids may be gently taped closed or protected with an eye shield to prevent spontaneous eversion and reduce mechanical trauma to the ocular surface.

Treatment of Obstructive Sleep Apnea

Associated obstructive sleep apnea should be actively treated. CPAP therapy is a central treatment for appropriate patients and may improve the eyelid disorder in addition to reducing the systemic consequences of sleep apnea.

Depending on the severity and cause of OSA, additional management may include behavioral measures, weight management, mandibular advancement devices, or selected surgical procedures.

Additional Medical Treatment

In selected patients with significant inflammatory or meibomian gland-related disease, systemic therapy such as doxycycline may be considered by the treating clinician.

Treatment should also address associated ocular surface inflammation, blepharitis, keratoconus, or exposure keratopathy when present.

Surgical Treatment

Surgery is considered when conservative treatment and management of associated sleep apnea fail to provide adequate control.

When possible, significant obstructive sleep apnea should be addressed before definitive eyelid surgery.

Surgical options primarily aim to restore normal eyelid tension. These include horizontal eyelid shortening or canthal tightening procedures and, in selected cases, full-thickness eyelid resection.

Surgical treatment may simultaneously improve associated ptosis in some patients.

Recurrence can occur, and some patients eventually require additional eyelid procedures.

Follow-Up

Patients with active ocular surface disease require relatively close ophthalmologic follow-up, particularly when there is corneal involvement.

The cornea should be monitored for epithelial breakdown, exposure keratopathy, ulceration, infection, thinning, and scarring.

Long-term follow-up should also assess the effectiveness of sleep apnea treatment and the persistence or recurrence of eyelid laxity.

Patient Education

Patients should understand the particularly important relationship between floppy eyelid syndrome and obstructive sleep apnea.

Symptoms such as loud snoring, witnessed apnea, morning headaches, excessive daytime sleepiness, or unexplained fatigue should prompt appropriate sleep evaluation.

Patients should also be instructed to minimize eye rubbing and nocturnal mechanical trauma and to use prescribed lubrication and nighttime eyelid protection consistently.

Prognosis

The prognosis is generally favorable when both the ocular surface disease and associated sleep apnea are appropriately treated.

Treatment of obstructive sleep apnea with CPAP may improve floppy eyelid syndrome in some patients and, more importantly, reduces the substantial systemic risks associated with untreated sleep apnea.

Persistent severe eyelid laxity may require surgical correction, and recurrence after surgery is possible.

Complications

Chronic exposure and mechanical trauma can lead to corneal abrasion, epithelial breakdown, ulceration, infection, scarring, thinning, and, in severe cases, corneal perforation.

Floppy eyelid syndrome and its strong association with obstructive sleep apnea have also been reported alongside important ophthalmic disorders such as keratoconus, normal-tension glaucoma, nonarteritic ischemic optic neuropathy, and papilledema.


Image description
Published on

Ophthalmology – Fetal Alcohol Syndrome

Fetal alcohol syndrome (FAS) represents the most severe end of the fetal alcohol spectrum disorders (FASD), a group of developmental abnormalities caused by prenatal alcohol exposure. FAS is characterized by abnormalities in three major domains: growth restriction, characteristic facial features, and central nervous system dysfunction or structural abnormalities.

Typical facial features include short palpebral fissures, a thin upper vermilion border, and a smooth philtrum. Growth restriction is generally defined as height or weight at or below the 10th percentile. Central nervous system abnormalities may include structural brain anomalies, reduced head circumference, developmental impairment, or neurobehavioral dysfunction.

FAS may be diagnosed either with or without confirmed maternal alcohol exposure, although a documented history strengthens the diagnosis. Partial FAS is used when characteristic facial abnormalities are present but only one of the other major diagnostic domains is fulfilled.

Epidemiology and Risk Factors

The estimated prevalence of FAS is approximately 0.5–2 cases per 1,000 live births, although true rates vary between populations and are difficult to determine because prenatal alcohol exposure is frequently underreported.

The major risk factor is maternal alcohol consumption during pregnancy. Heavy daily intake and binge drinking carry particularly high risk, but a completely safe threshold has not been established.

Genetic factors may modify susceptibility. Variants in genes involved in alcohol metabolism, including ADH1B and CYP2E1, have been investigated as possible modifiers of fetal risk. However, prenatal alcohol exposure remains the essential causal factor.

Prevention

FAS is considered preventable by avoiding alcohol during pregnancy. Because alcohol exposure can occur before pregnancy is recognized, avoidance is also important when pregnancy is planned or possible.

Screening for unhealthy alcohol use and appropriate behavioral counseling before and during pregnancy can reduce fetal exposure.

Pathophysiology

Alcohol is a proven teratogen. The precise mechanisms by which it damages the developing fetus are complex and incompletely understood.

Ethanol and its metabolites, including acetaldehyde, can interfere with embryonic development during critical periods of gastrulation and neurulation. Proposed mechanisms include oxidative stress, free-radical formation, interference with cellular signaling, altered gene transcription, impaired neural crest development, and disruption of neuronal proliferation and migration.

Because the eyes and central nervous system develop closely together, prenatal alcohol exposure can affect the eyelids, globe, retina, optic nerve, and visual pathways.

Associated Systemic Features

Children with FAS may have growth restriction, developmental delay, learning disabilities, reduced IQ, behavioral disorders, poor adaptive functioning, impaired social judgment, and communication difficulties.

Attention-deficit/hyperactivity disorder and other psychiatric or behavioral disorders are common. Some affected individuals later develop problems with substance use and mental health.

Congenital heart defects and other systemic malformations may also occur.

Ophthalmic Manifestations

Ocular abnormalities are common in FAS. External features may include short palpebral fissures, ptosis, epicanthal folds, and telecanthus.

The globe may be smaller than normal, producing microphthalmos.

Strabismus, particularly esotropia, is common and can lead to amblyopia if untreated.

Visual acuity may be reduced in one or both eyes. Refractive errors are also common, with myopia frequently reported.

Anterior segment abnormalities and media opacities can occur. Posterior segment findings may include retinal dysplasia and tortuous retinal vessels.

One of the most important abnormalities is optic nerve hypoplasia, which may cause substantial and permanent visual impairment.

Severely affected children may also have cortical visual impairment, reflecting damage to central visual pathways rather than the eyes themselves.

Diagnosis

A careful prenatal history should assess possible maternal alcohol exposure, although clinicians should recognize that alcohol consumption may be underestimated or underreported.

The physical examination should evaluate growth, head circumference, characteristic facial features, neurologic development, and associated congenital abnormalities.

A complete ophthalmic evaluation should assess visual acuity or age-appropriate visual behavior, ocular alignment, eyelid anatomy, cycloplegic refraction, anterior segment structures, retina, and optic nerves.

Because visual problems can interfere further with development and learning, ophthalmologic abnormalities should be identified as early as possible.

Diagnostic Testing

There is currently no single reliable laboratory test that confirms fetal alcohol syndrome.

Several biochemical markers of maternal alcohol exposure have been investigated, including fatty acid ethyl esters in meconium or hair, gamma-glutamyl transferase, carbohydrate-deficient transferrin, and acetaldehyde-associated markers. None is sufficiently sensitive and specific to replace clinical diagnosis.

CT or MRI of the brain may be useful when structural central nervous system abnormalities are suspected.

Electroretinography has shown variable findings and is not a standard diagnostic test for FAS.

Differential Diagnosis

Several genetic and congenital syndromes can resemble the facial or ophthalmic findings of FAS. Important differential diagnoses include velocardiofacial syndrome, Williams syndrome, blepharophimosis syndrome, and Dubowitz syndrome.

Because prenatal alcohol exposure may coexist with an unrelated genetic disorder, atypical features should prompt consideration of clinical genetics or dysmorphology consultation.

Treatment

There is no medication that reverses the congenital ocular abnormalities of FAS. Management is therefore directed toward maximizing visual development and treating specific ocular problems.

Refractive errors should be corrected promptly with appropriate spectacles or other optical correction.

If amblyopia is present, treatment may include patching of the better-seeing eye or other standard amblyopia therapy.

Strabismus surgery may be indicated when significant ocular misalignment persists despite optical and amblyopia treatment.

Ptosis surgery may be considered when eyelid drooping interferes with the visual axis or causes significant functional impairment.

Children with optic nerve hypoplasia, cortical visual impairment, or other permanent visual deficits may benefit from low-vision and developmental services.

Associated systemic and neurodevelopmental disorders require multidisciplinary care.

Follow-up

Children with FAS should have ongoing ophthalmologic follow-up, particularly during the amblyogenic years.

Monitoring should include visual acuity, refractive error, ocular alignment, amblyopia, ptosis, and optic nerve function.

The frequency of follow-up depends on the severity of ocular involvement. Children with significant strabismus, amblyopia, or refractive error require more frequent examinations.

Patient Education

Families should understand that many behavioral, developmental, and learning problems are manifestations of the underlying neurodevelopmental disorder and may require long-term educational, behavioral, and medical support.

Parents should also understand the importance of early treatment of refractive error and strabismus, because preventable amblyopia can compound visual impairment caused by FAS.

When ongoing maternal alcohol misuse is identified, referral for appropriate substance-use treatment and support services is important.

Prognosis

Visual prognosis depends on the specific ocular abnormalities. Children whose reduced vision is primarily caused by refractive error or amblyopia can improve substantially when diagnosed and treated early.

Visual loss from optic nerve hypoplasia, retinal abnormalities, or cortical visual impairment may be permanent.

Early ophthalmologic evaluation in infancy or the preschool years provides the best opportunity to preserve useful vision and prevent avoidable visual disability.

Complications

The major ophthalmic complication is permanent reduction in visual acuity from untreated amblyopia, particularly when associated with strabismus, anisometropia, or significant refractive error.

More severe congenital abnormalities, including optic nerve hypoplasia and cortical visual impairment, can cause substantial lifelong visual disability.


Image description
Published on

Ophthalmology – Familial Exudative Vitreoretinopathy

Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal vascular disorder in which abnormal development of the retinal circulation leaves an area of peripheral avascular retina. The resulting peripheral retinal ischemia can stimulate neovascularization, exudation, fibrosis, vitreoretinal traction, retinal folds, macular ectopia, and tractional retinal detachment. Advanced disease may also produce cataract, neovascular glaucoma, and band keratopathy.

FEVR is usually bilateral, but the two eyes can be strikingly asymmetric. Disease severity varies enormously, even among members of the same family and between the two eyes of a single patient. Many affected individuals remain asymptomatic throughout life, whereas others develop severe visual loss or complete blindness in infancy. Importantly, FEVR can progress even after many years of apparent stability.

Epidemiology and Genetics

The true incidence and prevalence are unknown because many affected individuals have mild disease and remain undiagnosed. Molecular and family studies suggest that a very large proportion of affected people may be asymptomatic.

The most common inheritance pattern is autosomal dominant, although autosomal recessive and X-linked forms also occur. Penetrance is high when careful peripheral retinal examination and fluorescein angiography are used, but clinical expression is extremely variable.

Several genes involved in the Norrin–β-catenin signaling pathway have been associated with FEVR. Important genes include FZD4, NDP, LRP5, and TSPAN12. This pathway is essential for normal retinal vascular development.

Mutations in NDP can also cause Norrie disease, an X-linked disorder characterized by severe congenital retinal disease and sometimes hearing loss and developmental abnormalities.

Patients with LRP5-associated FEVR may have reduced bone mass, so systemic skeletal assessment may occasionally be relevant.

Pathophysiology

The primary abnormality in FEVR is incomplete peripheral retinal vascularization. Defective signaling in pathways responsible for retinal vasogenesis leaves an avascular peripheral retina, most commonly temporally.

This avascular retina becomes relatively ischemic and can stimulate production of angiogenic factors. Secondary changes may include abnormal vascular branching, arteriovenous shunts, neovascularization, lipid exudation, and fibrovascular proliferation.

As fibrovascular tissue contracts, it produces vitreoretinal traction, which can drag the macula and optic disc temporally, create retinal folds, and eventually cause tractional retinal detachment. Some eyes may also develop retinal breaks and combined tractional-rhegmatogenous detachment.

Clinical Presentation

A detailed history should include a family history of retinal disease, visual loss, retinal detachment, or childhood blindness. It is also important to ask about prematurity and neonatal oxygen exposure, because retinopathy of prematurity can closely resemble FEVR.

Many affected individuals are asymptomatic and are diagnosed only after examination of family members of a known case.

Infants with severe disease may present with poor fixation and following, pendular nystagmus, strabismus, or leukocoria caused by extensive retinal detachment or heavy lipid exudation.

Older children and adults may present with gradual or sudden visual loss due to retinal detachment, retinal folds, vitreous hemorrhage, or macular ectopia.

Some patients develop apparent exotropia because temporal displacement of the macula produces a large positive angle kappa, creating pseudoexotropia.

Physical Examination

Visual acuity ranges from normal to profound visual loss. A complete dilated retinal examination with careful peripheral evaluation and scleral depression is essential.

The hallmark finding is a peripheral avascular zone, usually most prominent temporally but sometimes extending circumferentially.

At the vascular-avascular junction, retinal vessels may have a brush-like appearance, excessive branching, dilation, tortuosity, or abnormal peripheral looping.

Additional findings can include peripheral neovascularization, vitreous hemorrhage, subretinal lipid exudation, vitreoretinal fibrosis, retinal folds, macular ectopia, temporal dragging of the retina and optic disc, and tractional retinal detachment.

Fluorescein Angiography

Fluorescein angiography, preferably with wide-field peripheral imaging, is one of the most useful diagnostic tests.

Typical angiographic abnormalities include abrupt termination of the peripheral capillary bed, avascular peripheral retina, abnormal peripheral vessel branching, arteriovenous shunts, vascular tortuosity, leakage from abnormal peripheral vessels, and temporal dragging of retinal vessels.

Wide-field angiography is particularly valuable because clinically subtle disease may become obvious only when the far peripheral circulation is examined.

Differential Diagnosis

The condition that most closely resembles FEVR is retinopathy of prematurity (ROP). The distinction depends heavily on history. ROP occurs in premature infants, particularly those with a history of neonatal intensive care and oxygen exposure, whereas FEVR may occur in full-term infants and often has a positive family history.

Other differential diagnoses include persistent fetal vasculature, Norrie disease, X-linked retinoschisis, incontinentia pigmenti, Coats disease, pars planitis, and ocular toxocariasis.

The combination of a peripheral avascular retina, asymmetric bilateral disease, and a positive family history strongly supports FEVR.

Treatment

Treatment is determined by the stage and activity of disease.

Eyes with peripheral avascular retina alone, without neovascularization, exudation, or traction, are usually observed.

When significant peripheral neovascularization or exudation develops, laser photocoagulation to the avascular peripheral retina is commonly used. Cryotherapy can also be considered when laser treatment is technically difficult.

The goal is to reduce ischemic drive and prevent progression to fibrovascular traction and retinal detachment.

Anti-VEGF agents have been used in selected cases with severe exudative or neovascular disease, but their role requires caution because rapid regression of neovascular tissue may potentially increase fibrovascular contraction and traction. They are therefore generally considered adjunctive rather than routine therapy.

Surgical Management

Eyes with retinal detachment require treatment according to the extent and mechanism of traction.

Mild tractional detachment that does not involve the fovea may sometimes be managed with scleral buckling.

More advanced tractional retinal detachment generally requires pars plana vitrectomy, often with membrane dissection and other vitreoretinal techniques. Complex cases may require combined vitrectomy and scleral buckle procedures.

Surgery can be technically difficult because of abnormal peripheral vasculature and extensive vitreoretinal adhesions.

Follow-up

Long-term monitoring is essential because FEVR can remain stable for years and subsequently reactivate or progress.

Patients with only peripheral avascularity and no active complications may sometimes be followed annually.

Patients with neovascularization, exudation, or traction require much closer follow-up, particularly during periods of active treatment.

Children require particularly careful surveillance because progression can occur rapidly and because retinal pathology may interfere with visual development and cause amblyopia or strabismus.

Family Screening and Genetic Counseling

Because FEVR is inherited and may be clinically subtle, first-degree relatives should undergo retinal examination, often including wide-field fluorescein angiography when indicated.

Genetic counseling should be offered according to the identified or suspected mode of inheritance. Molecular testing can be helpful for confirming the diagnosis and screening family members, although a negative genetic test does not exclude FEVR because not all causative genes are known.

Prognosis

The prognosis is highly variable. Patients with mild peripheral vascular abnormalities may maintain normal vision throughout life, whereas those presenting in infancy with extensive retinal detachment generally have a poorer visual prognosis.

Early recognition of neovascularization and exudation before significant retinal traction develops provides the best opportunity to preserve useful vision.

Even apparently stable patients require lifelong follow-up because progression can occur after prolonged periods of inactivity.

Complications

Major complications include peripheral neovascularization, vitreous hemorrhage, lipid exudation, arteriovenous malformations, vitreoretinal fibrosis, falciform retinal folds, macular ectopia, retinal tears, tractional or combined retinal detachment, cataract, neovascular glaucoma, and blindness.


Image description
Published on

Ophthalmology – Fabry’s Disease

Fabry disease, also called Anderson–Fabry disease or α-galactosidase A deficiency, is a rare X-linked lysosomal storage disorder caused by mutation of the GLA gene, which encodes the enzyme α-galactosidase A. Deficiency of this enzyme leads to accumulation of glycosphingolipids, particularly globotriaosylceramide (GL-3 or Gb3), within lysosomes throughout the body. Progressive accumulation produces dysfunction of vascular endothelial and smooth-muscle cells and ultimately damages the kidneys, heart, nervous system, skin, and eyes.

Fabry disease is potentially life-threatening if untreated. Historically, life expectancy was substantially shortened, especially in males, because of renal failure, cardiomyopathy, arrhythmias, and premature cerebrovascular disease. Females can also develop significant disease despite the X-linked inheritance pattern because random X-chromosome inactivation can result in substantial expression of the abnormal gene.

Epidemiology and Genetics

The traditionally estimated incidence ranges from approximately 1 in 40,000 to 1 in 170,000, although newborn screening programs have identified pathogenic variants much more frequently. The disorder results from mutations in the GLA gene located on Xq22.1.

Affected males generally have markedly reduced enzyme activity and more severe classical disease. Heterozygous females may range from asymptomatic to severely affected. A positive family history is therefore an important risk factor.

Genetic counseling is recommended for affected families. Prenatal diagnosis can be performed when the familial mutation is known, and molecular testing can identify affected relatives and carriers.

Pathophysiology

α-Galactosidase A normally participates in degradation of glycosphingolipids within lysosomes. When the enzyme is deficient, GL-3 and related substances accumulate progressively within cells.

Accumulation is particularly prominent in vascular endothelial cells, pericytes, smooth-muscle cells, renal cells, cardiac myocytes, and neurons. This produces progressive vascular dysfunction, tissue ischemia, inflammation, fibrosis, and organ damage.

Ocular Manifestations

Ocular findings often develop early in life and may provide an important clue to the diagnosis. The most characteristic finding is cornea verticillata, also called vortex keratopathy. This appears as fine, whorl-like deposits in the corneal epithelium, usually beginning inferiorly and forming a vortex pattern across the cornea.

Cornea verticillata is extremely common in Fabry disease and may occur in both males and females. Despite its striking appearance, it usually causes little or no visual impairment.

A second characteristic ocular manifestation is the Fabry cataract. Posterior lens opacities may have a distinctive spoke-like appearance, while wedge-shaped anterior lens opacities can also occur.

The conjunctival and retinal vessels may demonstrate increased tortuosity and aneurysmal dilation. These vascular changes usually do not significantly reduce vision but are useful diagnostic signs.

Systemic Manifestations

A characteristic dermatologic feature is the presence of angiokeratomas, which are small, nonblanching, dark-red to blue-black vascular lesions. They are typically concentrated between the umbilicus and knees, producing the classic “bathing-trunk” distribution.

Patients commonly develop hypohidrosis or anhidrosis, meaning decreased or absent sweating. This can result in heat intolerance and difficulty exercising.

Neurologic manifestations include acroparesthesias, consisting of recurrent burning or severe pain in the hands and feet. These pain crises frequently begin in childhood or adolescence and may be triggered by fever, exercise, emotional stress, or temperature changes.

Cerebrovascular disease can lead to transient ischemic attacks and strokes at relatively young ages. Hearing loss may also occur.

Renal disease usually begins with proteinuria or albuminuria and may progress to chronic kidney disease and eventually end-stage renal failure.

Cardiac manifestations include left ventricular hypertrophy, cardiomyopathy, valvular abnormalities, conduction disturbances, arrhythmias, and myocardial ischemic disease.

Diagnosis

Classical Fabry disease often begins in childhood or adolescence with a combination of pain crises, angiokeratomas, abnormal sweating, gastrointestinal symptoms, and ocular abnormalities. Renal, cardiac, and cerebrovascular complications become increasingly prominent with age.

Late-onset forms may present initially with otherwise unexplained cardiomyopathy, left ventricular hypertrophy, renal dysfunction, or stroke.

A complete ophthalmic examination may demonstrate cornea verticillata, characteristic lens opacities, and tortuous conjunctival or retinal vessels.

Laboratory Testing

In males, measurement of α-galactosidase A activity in plasma or leukocytes is an important diagnostic test. Markedly decreased enzyme activity strongly supports Fabry disease.

Enzyme activity may be normal in heterozygous females because of variable X-chromosome inactivation. Therefore, molecular genetic testing of the GLA gene is particularly important in females and is also useful for confirming the diagnosis in males.

Urinalysis may demonstrate proteinuria, and progressive renal disease may lead to elevated creatinine and reduced glomerular filtration.

Additional evaluation should assess systemic involvement. Cardiac testing may include ECG and echocardiography, while MRI or other neurologic imaging may be indicated for cerebrovascular manifestations.

Differential Diagnosis

The major differential diagnosis for cornea verticillata is drug-induced vortex keratopathy. Similar corneal deposits may occur with long-term use of medications such as amiodarone, chloroquine or hydroxychloroquine, tamoxifen, indomethacin, and several other drugs.

Angiokeratomas may occur in other lysosomal storage disorders and can also resemble petechiae or other vascular skin lesions.

The neuropathic pain of Fabry disease may initially be mistaken for rheumatologic disease, erythromelalgia, Raynaud phenomenon, juvenile arthritis, or other neurologic conditions.

A combination of cornea verticillata, angiokeratomas, acroparesthesias, decreased sweating, and unexplained renal or cardiac disease should strongly suggest Fabry disease.

Treatment

Fabry disease requires multidisciplinary management. The main disease-specific treatment is enzyme replacement therapy (ERT) with recombinant α-galactosidase A. Treatment is most beneficial when started before irreversible renal, cardiac, or neurologic injury has occurred.

Depending on the underlying mutation and local treatment availability, selected patients may also be candidates for pharmacologic chaperone therapy.

Neuropathic pain can be treated with medications such as carbamazepine or gabapentin.

Renal disease should be managed aggressively, particularly hypertension and proteinuria. Medications that inhibit the renin–angiotensin system may be useful when clinically appropriate.

Cardiovascular risk factors should also be controlled. Antiplatelet, lipid-lowering, antihypertensive, and antiarrhythmic therapy may be prescribed depending on the individual patient’s vascular and cardiac manifestations.

Advanced renal failure may require hemodialysis or kidney transplantation.

Angiokeratomas may be treated with laser therapy if they are symptomatic or cosmetically troublesome.

The ocular findings generally require no specific treatment, because cornea verticillata and Fabry cataract usually have little effect on visual acuity.

Follow-up

Fabry disease requires lifelong multidisciplinary follow-up. Patients should undergo regular renal, cardiac, neurologic, ophthalmic, and hearing evaluations.

Renal monitoring should include assessment of proteinuria, serum creatinine, and kidney function. Cardiac surveillance commonly involves ECG and echocardiographic or other cardiac imaging. Neurologic follow-up is important because of the risk of early stroke and other cerebrovascular complications.

Ophthalmologic examinations can document characteristic ocular findings and monitor for unrelated causes of visual loss.

Because Fabry disease is inherited, appropriate family members should be offered genetic testing.

Patient Education

Patients should understand that Fabry disease is a lifelong systemic disorder requiring coordinated care involving specialists such as nephrologists, cardiologists, neurologists, geneticists, dermatologists, and ophthalmologists.

Lifestyle measures that reduce cardiovascular risk, including appropriate diet, exercise when tolerated, and control of blood pressure and lipid levels, are important components of long-term care.

Prognosis

Without appropriate treatment, Fabry disease can lead to progressive renal failure, cardiomyopathy, arrhythmias, stroke, and premature death.

With earlier diagnosis, disease-specific therapy, and modern renal and cardiovascular management, the prognosis has improved considerably. Treatment can slow organ damage and reduce the severity of several systemic manifestations.

A particularly important ophthalmic clue is the combination of cornea verticillata, spoke-like lens opacities, and tortuous conjunctival or retinal vessels. These findings usually do not threaten vision, but they may allow an ophthalmologist to recognize Fabry disease before serious systemic complications become apparent.


Published on

Ophthalmology – Eyelid Neoplasms, Malignant


Malignant eyelid neoplasms can arise from virtually any tissue of the ocular adnexa. Early recognition is critical because these tumors can cause local tissue destruction, orbital invasion, lymphatic or hematogenous spread, visual loss, and potentially death. The major malignant eyelid tumors are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sebaceous gland carcinoma, and malignant melanoma. Less common malignant lesions include Merkel cell carcinoma, Kaposi sarcoma, cutaneous T-cell lymphoma, and MALT lymphoma.


Approximately 5–10% of all skin cancers involve the eyelid. Basal cell carcinoma is by far the most common malignant eyelid tumor, accounting for approximately 80–90% of cases. Squamous cell carcinoma accounts for roughly 5–10%, sebaceous carcinoma for approximately 1–5%, and malignant melanoma for about 1% or less.


The most important risk factor is chronic ultraviolet exposure. Other risk factors include fair skin, Caucasian ethnicity, advanced age, previous skin cancer, immunosuppression, previous radiation, chronic scars or burns, and arsenic exposure. Preventive measures therefore include limiting excessive sun exposure and using appropriate UV protection, especially from childhood onward.


Pathophysiology


Chronic ultraviolet radiation can cause mutations and defects in DNA repair pathways. When damaged cells escape normal regulatory mechanisms, they may undergo malignant transformation and proliferate uncontrollably.


The biologic behavior varies considerably among tumor types. Some lesions, such as BCC, are usually slow growing and rarely metastasize but can become profoundly locally destructive. Others, particularly sebaceous carcinoma and melanoma, possess substantial metastatic potential.



Basal Cell Carcinoma


Basal cell carcinoma arises from basal cells of the epidermis. It is the most common malignant eyelid tumor and most frequently involves the lower eyelid, followed by the medial canthus, upper eyelid, and lateral canthus.


BCC generally grows slowly and metastasizes only rarely. However, it can be locally invasive, particularly when located near the medial canthus, where spread into the orbit and adjacent structures may occur before the extent of disease is clinically obvious.


The classic form is a pearly, firm, indurated nodule with surface telangiectatic vessels, sometimes accompanied by central ulceration. Nodulo-ulcerative lesions may produce the characteristic appearance of a central ulcer with raised pearly borders.


The morpheaform or sclerosing subtype is flatter and more infiltrative. It may appear as a firm, pale or yellow-white plaque with indistinct borders and relatively intact overlying epidermis. Because the clinical margins are poorly defined, complete removal can be more difficult.


Superficial multifocal BCC involves a broader area of the epidermis and dermis and may have a more irregular surface.



Squamous Cell Carcinoma


Squamous cell carcinoma arises from the squamous epithelial layer of the epidermis. Unlike BCC, SCC may develop from premalignant lesions such as actinic keratosis, Bowen disease, or radiation-related skin damage.


The lower eyelid is the most common site, followed by the medial canthus, upper eyelid, and lateral canthus. SCC may present as a painless nodule, plaque, ulcerated lesion, or crusted lesion and can sometimes resemble basal cell carcinoma.


SCC has a greater tendency than BCC to metastasize to regional lymph nodes. Particularly concerning is perineural invasion, because tumor cells can track along nerves into the orbit, intracranial cavity, or surrounding facial structures.


Histologically, invasive SCC demonstrates atypical squamous cells crossing the basement membrane into the dermis, often with keratin pearls and dyskeratotic cells.



Sebaceous Gland Carcinoma


Sebaceous gland carcinoma most commonly arises from the meibomian glands of the eyelid or the glands of Zeis. It is an especially important tumor because it frequently masquerades as a benign inflammatory disorder.


It may present as a recurrent or persistent chalazion, chronic unilateral blepharitis, or blepharoconjunctivitis. For this reason, it is often called the “great masquerader.”


The upper eyelid is commonly involved because it contains a greater number of meibomian glands.


A key clinical warning sign is loss of eyelashes (madarosis) in the region of the lesion. Sebaceous carcinoma can be multicentric and may spread within the epithelium in a pagetoid pattern, involving areas beyond the clinically visible tumor.


The tumor can spread directly into the orbit, paranasal sinuses, and intracranial structures, and can metastasize through lymphatic pathways to regional lymph nodes and distant organs.


Because recurrence after treatment is possible, long-term surveillance is essential.



Malignant Melanoma


Malignant melanoma of the eyelid results from malignant proliferation of melanocytes. Although uncommon, melanoma is clinically important because it has significant metastatic potential and is a major cause of death from primary skin tumors.


Major forms include superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, and acral lentiginous melanoma.


Superficial spreading melanoma may appear as an elevated lesion with irregular pigmentation containing combinations of black, brown, tan, rose, gray, or blue.


Nodular melanoma typically forms a raised spherical lesion with a relatively uniform blue-black appearance.


Lentigo maligna melanoma develops from a longstanding pigmented macule that later develops elevation or nodularity.


Tumor thickness is an important prognostic factor. Breslow thickness, which measures the depth of invasion in millimeters, is more clinically important than the older Clark level classification.


Patients require careful systemic assessment because metastatic melanoma can involve regional lymph nodes and distant organs.



Associated Genetic and Systemic Conditions


Several inherited syndromes substantially increase the risk of malignant eyelid tumors.


Gorlin–Goltz syndrome, or basal cell nevus syndrome, is an autosomal dominant disorder caused by mutations involving the PTCH gene. Patients develop multiple basal cell carcinomas, sometimes beginning in childhood, along with jaw cysts, skeletal abnormalities, and characteristic pits of the palms and soles.


Bazex syndrome is an X-linked dominant disorder associated with early development of multiple facial basal cell carcinomas and characteristic atrophic skin changes.


Xeroderma pigmentosum is an autosomal recessive disorder involving defective DNA repair. Patients develop multiple BCCs, SCCs, and melanomas at unusually young ages because of extreme sensitivity to ultraviolet radiation.


Patients with albinism have decreased protective melanin and therefore have a substantially increased risk of ultraviolet-induced skin malignancies.



Diagnosis


Any persistent or suspicious eyelid lesion should undergo careful evaluation. Important historical features include duration, rate of growth, previous skin cancer, previous radiation exposure, arsenic exposure, chronic inflammatory disease, and significant UV exposure.


A lesion that repeatedly recurs after treatment as a benign condition deserves particular attention. For example, a “chalazion” that repeatedly returns in the same location should raise concern for sebaceous gland carcinoma.


Physical Examination


The eyelid lesion should be examined carefully for ulceration, abnormal pigmentation, irregular texture, persistent crusting, spontaneous bleeding, and loss of normal eyelid architecture.


Loss of eyelashes, or madarosis, is an especially important sign. Poliosis, or whitening of eyelashes, may also occur.


Abnormal vascularity should be documented. Feeder vessels and telangiectatic vessels at the tumor margins are concerning features.


Signs such as proptosis, diplopia, restricted ocular motility, or external ophthalmoplegia suggest possible orbital invasion and require urgent further evaluation.


Regional lymph nodes, particularly the preauricular, submandibular, and cervical nodes, should be examined for enlargement.



Biopsy and Histopathology


Histopathologic confirmation is essential for suspected malignant eyelid tumors.


In many lesions, an incisional biopsy can establish the diagnosis before definitive treatment. However, melanoma requires careful biopsy planning because depth of invasion is essential for staging and prognosis.


Basal cell carcinoma typically demonstrates nests of basaloid cells with peripheral palisading.


Squamous cell carcinoma demonstrates atypical squamous cells, often with keratinization and keratin pearls, invading through the basement membrane.


Sebaceous gland carcinoma shows large atypical cells containing foamy lipid-rich cytoplasm, prominent nuclei, and infiltrative growth in lobules, cords, and nests. Pagetoid epithelial spread may also be present.


Melanoma demonstrates atypical melanocytes with abnormal proliferation, loss of normal maturation, and potentially pagetoid upward migration through the epidermis.



Treatment


Treatment depends on the tumor type, size, location, depth, and extent of spread.


For basal cell carcinoma and squamous cell carcinoma, complete surgical removal with margin control is the standard approach. Techniques include Mohs micrographic surgery or excision with frozen- or permanent-section margin assessment. These approaches provide high cure rates while preserving as much normal eyelid tissue as possible.


For sebaceous gland carcinoma, treatment typically involves complete excision with careful margin control. Because of the possibility of pagetoid spread, conjunctival map biopsies may be required. Additional therapy may be considered when microscopic disease persists. Extensive orbital invasion may necessitate orbital exenteration.


Management of malignant melanoma depends heavily on tumor thickness and stage. Surgical excision with appropriate margins is required, while selected patients may need sentinel lymph node biopsy, lymphatic mapping, and systemic oncologic management.


Radiotherapy may be considered in selected patients when surgery is contraindicated or as an adjunct in particular tumor types.



Follow-up


Patients generally require close postoperative follow-up initially to ensure adequate wound healing and confirm that no early recurrence is present.


Long-term surveillance is essential. Stable lower-risk tumors may be followed approximately every 6–12 months, while aggressive tumors such as sebaceous carcinoma and melanoma require more frequent and prolonged monitoring.


Patients should also undergo regular full-body skin examinations through a dermatologist or primary care physician because the presence of one skin malignancy increases the likelihood of additional lesions.


Patients with sebaceous carcinoma or melanoma often require coordinated follow-up with medical oncology, while radiation oncology may be involved when radiotherapy is required.



Patient Education


Patients should be encouraged to minimize ultraviolet exposure by using sunscreen, hats, sunglasses, and other protective measures.


Any new or recurrent eyelid lesion showing growth, ulceration, bleeding, color change, loss of eyelashes, persistent crusting, or alteration of normal eyelid architecture should be evaluated promptly.


Patients previously treated for an eyelid malignancy should understand that long-term surveillance is necessary because recurrence or development of a second skin cancer can occur.



Prognosis and Complications


The prognosis depends heavily on the specific tumor type, stage at diagnosis, and adequacy of surgical excision.


Early basal cell carcinoma generally has an excellent prognosis when completely removed, whereas advanced SCC, sebaceous carcinoma, and melanoma carry greater risks of regional and systemic spread.


Potential complications include destruction of eyelid anatomy, impaired eyelid function, orbital invasion, intracranial extension, lymphatic or distant metastasis, visual loss, and death.


The most important principle is early recognition and biopsy of suspicious eyelid lesions, because timely diagnosis can prevent extensive local destruction and potentially life-threatening metastatic disease.

Image description
Published on

Ophthalmology – Benign Eyelid Neoplasms

Benign eyelid neoplasms are nonmalignant proliferations arising from the numerous tissues that make up the eyelid. The eyelid contains the epidermis, dermis, and deeper adnexal structures, so benign lesions can arise from epithelial cells, melanocytes, vascular tissue, or the various eyelid glands.

The epidermis consists predominantly of keratinocytes but also contains melanocytes, Merkel cells, and Langerhans cells. Beneath it, the dermis contains blood vessels, nerves, and lymphatics. The deeper adnexal tissues include sebaceous, eccrine, apocrine, holocrine, and meibomian glands. Abnormal benign proliferation or obstruction involving any of these structures can produce an eyelid lesion.

Most eyelid tumors are benign, accounting for approximately 54–84% of eyelid tumors. Common lesions encountered in ophthalmic practice include chalazia, epidermal inclusion cysts, squamous papillomas, seborrheic keratoses, melanocytic nevi, hidrocystomas, xanthelasma, and capillary hemangiomas.

Epidemiology

The frequency varies considerably according to lesion type. Chalazia and epidermal inclusion cysts are among the most frequently encountered benign eyelid lesions in general ophthalmology.

Among surgically removed benign eyelid lesions, approximately 26% are squamous papillomas and 21% are seborrheic keratoses. Seborrheic keratoses become extremely common with increasing age and may be found in the majority of adults older than 50 years.

Capillary hemangioma is one of the most common eyelid tumors of infancy, occurring in approximately 1–2.6% of live births.

Risk Factors

Risk factors depend on the particular lesion. Meibomian gland dysfunction and ocular rosacea predispose to recurrent chalazia and hordeola. Previous eyelid trauma or surgery can lead to epidermal inclusion cyst formation because epidermal tissue may become implanted within the dermis.

Capillary hemangiomas are more common in females, with an approximate 3:1 female-to-male ratio.

Human papillomavirus may be associated with some squamous papillomas. Chronic ultraviolet exposure, increasing age, and substantial lifetime sun exposure predispose to several epithelial lesions and, more importantly, increase the risk of premalignant and malignant eyelid disease.

Hypercholesterolemia and familial disorders of lipid metabolism are associated with xanthoma and xanthelasma.

Prevention therefore includes appropriate UV protection and sunscreen, good eyelid hygiene in patients prone to inflammatory glandular disease, and management of systemic lipid abnormalities when appropriate.


Common Benign Eyelid Lesions

Chalazion

A chalazion is a chronic sterile lipogranulomatous inflammatory lesion caused by retention of sebaceous secretions, usually from a meibomian gland but occasionally involving the glands of Zeis.

The retained lipid triggers a granulomatous inflammatory reaction. A chalazion typically presents as a relatively painless, localized eyelid nodule. When an eyelid gland becomes acutely infected, the clinical lesion is generally termed a hordeolum.

Ocular rosacea and chronic meibomian gland dysfunction predispose to recurrent lesions.

Initial treatment consists of warm compresses and gentle massage, usually several times daily, together with appropriate eyelid hygiene. Topical antibiotics may be useful when there is associated blepharitis or drainage, although an uncomplicated chalazion itself is sterile.

Persistent lesions may require incision and curettage or intralesional corticosteroid injection. Triamcinolone injection can cause local skin depigmentation and atrophy. In patients with significant ocular rosacea or recurrent meibomian gland disease, systemic tetracycline-class therapy may sometimes be considered.

A particularly important clinical point is that a recurrent or atypical unilateral chalazion should raise suspicion for an eyelid malignancy, especially sebaceous carcinoma, and biopsy should be considered.

Epidermal Inclusion Cyst

An epidermal inclusion cyst is a superficial, usually round lesion containing keratin. It develops when epidermal tissue becomes trapped within the deeper dermis, sometimes following trauma or eyelid surgery.

Histologically, the cyst is lined by stratified squamous epithelium and contains keratinaceous material.

Treatment is generally performed for symptoms, enlargement, diagnostic uncertainty, or cosmetic reasons. The lesion can be completely excised with its capsule intact to minimize recurrence. Selected cystic lesions may instead be marsupialized.

Capillary Hemangioma

A capillary hemangioma of infancy is a benign vascular proliferation. It typically appears as a pink, red, or violaceous lesion and undergoes a characteristic natural history consisting of rapid proliferation, stabilization, and subsequent spontaneous involution.

Many lesions can therefore be observed. Approximately half regress substantially by 5 years of age and about 70% by 7 years, with continued improvement possible thereafter.

Observation is appropriate only when the lesion does not threaten vision or other important functions. Periocular hemangiomas require careful monitoring because they may cause visual-axis obstruction, astigmatism, anisometropia, strabismus, and amblyopia.

Large or strategically located lesions can also distort facial structures. Multiple cutaneous hemangiomas may occasionally be associated with visceral vascular lesions.

Treatment is indicated when there is a threat to visual development, rapid progression, significant anatomical distortion, ulceration, or other functional complications. Systemic propranolol has become an important treatment for problematic infantile hemangiomas, with therapy requiring appropriate pediatric assessment and monitoring. Corticosteroids, intralesional therapy, laser treatment, and other approaches may be considered in selected circumstances.

Squamous Cell Papilloma

A squamous papilloma is a benign epithelial proliferation that commonly forms a pedunculated lesion with finger-like projections. Histologically, it contains a vascular connective-tissue core surrounded by acanthotic and hyperkeratotic squamous epithelium.

Clinically benign lesions do not necessarily require treatment. They may be removed when they become irritated, repeatedly traumatized, bleed, enlarge, interfere with vision, or are cosmetically undesirable.

Any lesion with atypical features should be biopsied rather than assumed to be a benign papilloma.

Seborrheic Keratosis

Seborrheic keratosis is an extremely common benign epithelial lesion, particularly among older adults. It usually appears as a well-demarcated, gray-to-brown, greasy or scaly papule or plaque, often giving the impression that it has been “stuck onto” the skin.

These lesions arise from keratinocytes and demonstrate several different histopathologic patterns.

Treatment is optional for clearly benign lesions. Removal may be performed for irritation, bleeding, growth, or cosmetic reasons using techniques such as excision, cryotherapy, or selected ablative procedures.

Because pigmented or irregular seborrheic keratoses can occasionally resemble malignant lesions, diagnostic uncertainty should prompt biopsy.

Melanocytic Nevus

A melanocytic nevus consists of collections of melanocytes derived from the neural crest. Eyelid nevi can be flat or elevated, smooth or verrucous, and may range from deeply pigmented to essentially nonpigmented.

Histologically, nevi may be classified as junctional, compound, or intradermal according to the location of the nevus cells.

Stable lesions with a classic benign appearance can generally be observed. Changes in size, pigmentation, border, surface characteristics, ulceration, or bleeding warrant reassessment and possible biopsy.

Patients with numerous atypical or dysplastic nevi may have an increased lifetime risk of melanoma and require appropriate dermatologic surveillance.

Apocrine Hidrocystoma

An apocrine hidrocystoma is a benign cystic lesion commonly arising from the glands of Moll. Similar cystic lesions can originate from other eyelid glands.

They usually appear as smooth, translucent or bluish cystic nodules. Treatment is generally unnecessary unless the lesion causes symptoms or cosmetic concern.

Management may involve excision or marsupialization. Large or multiple lesions may occasionally be treated using other destructive techniques.

Xanthelasma and Xanthoma

Xanthelasma consists of yellowish lipid-containing plaques, classically occurring along the nasal aspect of the upper eyelids, although other periocular locations can be involved.

Histologically, these lesions contain lipid-laden histiocytes within the dermis.

Although many affected patients have normal lipid levels, xanthelasma can be associated with hypercholesterolemia or familial lipid disorders, particularly when it develops at a relatively young age. Appropriate patients should therefore undergo systemic evaluation of their cardiovascular and lipid risk factors.

Treatment is primarily cosmetic and may include surgical excision or laser-based treatment. Recurrence can occur even after successful removal.


Clinical Assessment

History is particularly important when evaluating an eyelid lesion. The clinician should determine how long the lesion has been present and whether it is changing in size, shape, pigmentation, or symptoms.

Most noninflammatory benign tumors are either stable or grow slowly. In contrast, rapid growth, spontaneous bleeding, ulceration, necrosis, or prominent abnormal vessels should raise concern for malignancy.

Previous skin cancers, systemic malignancies, eyelid surgery, trauma, radiation exposure, chronic inflammatory eyelid disease, and significant UV exposure should be documented.

Persistent unilateral “blepharitis” deserves particular attention because some malignant eyelid tumors, especially sebaceous carcinoma, may masquerade as chronic inflammatory eyelid disease.

Examination

Both eyelids and the surrounding adnexa should be examined carefully. The eyelid should be everted when appropriate to inspect the tarsal conjunctiva, particularly when sebaceous carcinoma or another infiltrative lesion is a concern.

The lesion should be evaluated for size, location, color, pigmentation, surface architecture, mobility, ulceration, necrosis, discharge, bleeding, and abnormal vascularity.

The eyelashes and meibomian glands should also be examined. Madarosis, meaning loss of eyelashes, is an important warning sign. Poliosis, destruction of meibomian gland architecture, or distortion of the eyelid margin should also be documented.

Regional preauricular, submandibular, and cervical lymph nodes should be examined when malignancy is suspected.

A complete slit-lamp examination should accompany evaluation of significant eyelid lesions, with further ocular examination dictated by the clinical findings.

Warning Signs for Malignancy

Although many eyelid lesions are benign, several features should make the clinician reconsider the diagnosis. Particularly concerning findings include rapid or progressive enlargement, ulceration, spontaneous bleeding, necrosis, destruction of the eyelid margin, loss of eyelashes, abnormal feeder vessels, fixation to deeper tissue, recurrent lesions after apparently adequate treatment, and regional lymphadenopathy.

A lesion that behaves atypically should not simply be treated repeatedly as a benign cyst or chalazion.


Investigations and Biopsy

Routine laboratory testing and imaging are generally unnecessary for a typical benign eyelid lesion.

Discharge can be cultured when infection is suspected. Systemic investigations may be appropriate when there is concern for an associated systemic disorder, such as lipid testing in selected patients with xanthelasma.

Imaging is reserved for lesions in which there is concern for orbital extension, deep tissue involvement, systemic disease, or malignancy.

When the diagnosis is uncertain, histopathologic examination is the definitive method of diagnosis. Depending on lesion size and clinical suspicion, either an incisional or excisional biopsy may be performed.


Management Principles

A clearly benign, asymptomatic lesion can often simply be observed. Treatment becomes appropriate when the lesion interferes with vision or eyelid function, causes recurrent irritation or bleeding, enlarges, is cosmetically unacceptable to the patient, or has uncertain diagnostic features.

Simple benign lesions may be treated with excision, marsupialization, cryotherapy, or other lesion-specific techniques.

When a lesion is clinically suspicious for malignancy, management changes substantially. Biopsy and histopathologic diagnosis are essential, and definitive treatment should follow oncologic principles rather than routine cosmetic removal.


Follow-up

Treated lesions should be monitored for recurrence. Apparent “recurrence” after excision may represent incomplete removal, development of a new lesion, or an initially incorrect diagnosis, so recurrent or changing lesions deserve reassessment and sometimes repeat biopsy.

Infants with periocular capillary hemangiomas require especially careful follow-up during the proliferative phase because amblyopia can develop rapidly if the lesion obstructs the visual axis or induces significant refractive error.

Patient Education

Patients should be encouraged to practice sun protection, including appropriate sunscreen and protective eyewear, particularly when they have substantial UV exposure or multiple sun-related skin lesions.

Those with xanthelasma may benefit from evaluation and management of systemic lipid abnormalities.

Patients should return for reassessment when an eyelid lesion develops rapid growth, bleeding, ulceration, pain, loss of eyelashes, color change, or recurrent growth after treatment.

Prognosis

The prognosis for true benign eyelid neoplasms is excellent. Many lesions require no treatment, while symptomatic or cosmetically troublesome lesions can usually be successfully removed.

The most important clinical challenge is not treatment of the benign lesion itself, but ensuring that an apparently harmless eyelid lesion is not actually a premalignant or malignant process masquerading as a benign condition.


Image description
Published on

Ophthalmology – Eyelid Laceration

Eyelid lacerations are traumatic cuts or tears involving the eyelid and may result from sharp trauma, blunt trauma, or diffuse facial trauma. They can involve the non-marginal eyelid, eyelid margin, or canalicular drainage system, sometimes with associated avulsion of the medial canthal tendon. Because eyelid trauma can coexist with serious ocular and orbital injuries, the first priority is always to exclude globe rupture, intraocular injury, orbital foreign body, optic nerve injury, and facial fractures.

Approximately 25% of eyelid injuries involve the eyelid margin, while around 15% involve the canalicular system. Canalicular lacerations are particularly common in young adults, with an average age around 24 years, and occur predominantly in males. Protective eyewear is important for prevention during hazardous work and recreational activities. Appropriate protective glasses should meet recognized standards such as ANSI Z87.1.

Pathophysiology and Mechanism

Sharp objects can directly cut through the eyelid skin, margin, or lacrimal drainage structures. Reported causes include fingernails, scissors, pencils, glass, tree branches, fishing equipment, and door handles.

Blunt or diffuse trauma can tear the eyelid by traction rather than direct penetration. Sudden lateral displacement of the eyelid can disrupt the medial canthal tendon and canaliculi, which is particularly important in injuries such as dog bites.

Eyelid lacerations frequently coexist with deeper injury. About 44% of eyelid trauma may be associated with globe injury, and patients with canalicular injuries may also have globe rupture, facial fractures, optic neuropathy, retinal detachment, or head trauma.

Diagnosis

The patient should first be stabilized for any life-threatening trauma. Once stable, a detailed history should establish when and how the injury occurred, including the type, direction, and velocity of the traumatic object. The mechanism can suggest an occult orbital or intraocular foreign body.

Previous visual status and tetanus immunization status should also be documented.

A complete ophthalmic examination is essential. Visual acuity should be checked whenever possible, and the clinician should carefully assess for open globe injury before manipulating the eyelid.

The laceration should be evaluated for its length, depth, and location. Determine whether it is partial or full thickness and whether the eyelid margin is involved.

Visible orbital fat prolapsing through the wound is an important finding because it indicates violation of the orbital septum and raises concern for deeper orbital injury, including possible levator damage.

Any laceration located medial to the punctum should be considered suspicious for canalicular injury until proven otherwise.

Diagnostic Testing

If the injury is small externally but resulted from penetrating trauma, there may still be a deeply retained foreign body. When the history or examination raises concern for an occult orbital foreign body, thin-cut CT of the orbits without contrast, with axial and coronal imaging, is generally appropriate.

When canalicular damage is suspected, an ophthalmologist may perform probing and irrigation of the lacrimal drainage system to determine whether the canaliculus has been disrupted.

Treatment

Tetanus immunization should be updated as appropriate.

Antibiotic use depends on the nature of the injury. Routine oral antibiotics for uncomplicated clean eyelid lacerations are not always necessary, but they may be considered based on contamination and mechanism. Animal and human bite injuries warrant prophylactic systemic antibiotics because of the increased risk of infection.

If the globe is intact, the wound can be kept moist with an appropriate dressing while awaiting definitive repair.

An apparently large tissue defect does not always mean that eyelid tissue has been lost. The skin and orbicularis muscle often retract after injury, creating the appearance of missing tissue. True tissue loss is less common but requires more complex reconstruction, often by an oculoplastic surgeon.

Surgical Repair

Repair may be performed in a procedure room or operating room depending on the extent of injury, patient cooperation, associated trauma, and need for sedation or general anesthesia.

Any globe injury should be repaired before the eyelid laceration.

Repair is generally performed within approximately 24–48 hours, although the exact timing depends on contamination, associated injuries, and tissue condition.

Simple non-marginal lacerations may be closed in layers. Deeper tissues can be approximated with absorbable sutures, followed by careful skin closure.

Eyelid-margin lacerations require precise anatomic repair to restore the normal contour and avoid postoperative notching, trichiasis, or poor eyelid-globe apposition. These injuries should be managed by an ophthalmic surgeon experienced in eyelid repair.

Canalicular lacerations require specialized repair, frequently using silicone intubation. Options include monocanalicular stents, such as a Mini-Monoka, or bicanalicular systems such as Crawford tubes, depending on the pattern of injury.

Follow-up

After repair, a thin layer of topical antibiotic ointment is generally applied to the wound several times daily.

Follow-up is commonly arranged within 3–7 days, depending on the severity and complexity of the injury. Patients with associated ocular trauma require follow-up appropriate to those injuries as well.

Hospital admission is usually unnecessary for an isolated eyelid laceration, but patients with a ruptured globe or significant associated trauma may require inpatient management.

Patient Education

Patients should be instructed to watch for signs of wound infection, particularly increasing redness, swelling, tenderness, pain, or discharge.

They should also be advised to return promptly for worsening vision, increasing ocular pain, new diplopia, or excessive tearing, because these symptoms may indicate associated ocular injury or lacrimal drainage complications.

Prognosis

The prognosis is usually very good when the injury is properly evaluated and anatomically repaired. Most patients achieve satisfactory functional and cosmetic outcomes.

Complications

Possible complications include infection, persistent tearing from canalicular obstruction, trichiasis, lagophthalmos with corneal exposure, eyelid-margin notching, and displacement of a silicone lacrimal stent.

Some patients require secondary procedures to correct persistent eyelid deformity, lacrimal dysfunction, or cosmetic abnormalities.


Image description